Temporary urethral stents ALLIUM BUS "BULBAR URETHRAL STENT" for the treatment of detrusor sphincter dyssynergia

被引:0
|
作者
Matillon, X. [1 ,2 ,3 ]
Terrier, J. -E. [1 ,2 ,3 ]
Arnouil, N. [2 ,3 ,4 ]
Lalloue, F. [1 ,2 ,3 ]
Pic, G. [1 ,2 ,3 ]
Ruffian, A. [1 ,2 ,3 ]
机构
[1] Ctr Hosp Lyon Sud, Serv Urol, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[2] Ctr Hosp Univ, Hosp Civils Lyon, F-69002 Lyon, France
[3] Univ Lyon 1, F-69100 Villeurbanne, France
[4] Hop Edouard Herriot, Serv Urol & Chirurg Transplantat, 5 Pl dArsonval, F-69003 Lyon, France
来源
PROGRES EN UROLOGIE | 2016年 / 26卷 / 09期
关键词
Detrusor sphincter dyssynergia; Urinary incontinence; Urethral stent; Neurogenic bladder; SPINAL-CORD-INJURY; EXTERNAL SPHINCTEROTOMY; MEN; COMPLICATIONS; MULTICENTER; DYSFUNCTION; MANAGEMENT; FRANCE;
D O I
10.1016/j.purol.2016.07.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The temporary prosthetic sphincterotomy is a possible treatment for neurologic detrusor sphincter dyssynergia (DSD). The purpose of the study was to verify the feasibility and effectiveness of the urethral stent (US) Temporary ALLIUM BUS "BULBAR URETHRAL STENT". Patients and methods. A prospective, non-comparative, single-center starting in 2015 was conducted. Were included patients over 18 years, with a neurologic DSD proved urodynamically for which medical treatment was not indicated or failed. The primary endpoint was the percentage of patients who had a voiding method considered as improved or much improved at 1 month and the feasibility of the procedure. Results. From January to June 2015, 7 patients, (mean age 47.9 years [24-76 years]) were prospectively enrolled. One patient was lost to sight at one month and therefore excluded. The median follow-up was 8.1 months (1-10 months). All procedures were technically successful. At 1 month, there were 57% of grade 2 complications (Clavien-Dindo), 1 of 6 patients had a migration of the US. At one month, quality of life and the urologic situation was considered good in 3 patients, unchanged in 2 patients and decreased in 1 patient. The study was stopped after the inclusion of seven patients. At the date of the latest news, 5 of 6 patients had a migrated or an explanted US. Conclusion. The temporary urethral stent ALLIUM BUS does not seem to be a possible surgical alternative for the treatment of detrusor sphincter dyssynergia. Level of evidence. 4. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:532 / 537
页数:6
相关论文
共 50 条
  • [41] What is new in detrusor-sphincter dyssynergia treatment in spinal cord injury patients?
    Schurch, B
    NEUROREHABILITATION, 1998, 10 (03) : 267 - +
  • [42] Impact of posterior urethral diameter/external urethral sphincter diameter as a new tool to predict detrusor pressure in the voiding phase
    Kon, Masafumi
    Mitsui, Takahiko
    Kitta, Takeya
    Moriya, Kimihiko
    Shinohara, Nobuo
    Takeda, Masayuki
    Nonomura, Katsuya
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (02) : 211 - 215
  • [43] BOTULINUM A TOXIN IN THE TREATMENT OF PATIENTS WITH DETRUSOR EXTERNAL SPHINCTER DYSSYNERGIA AND NEUROGENIC LOW DETRUSOR CONTRACTILITY
    Mazo, E. B.
    Krivoborodov, G. G.
    Efremov, N. S.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (10) : 49 - 52
  • [44] A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury
    Abdul-Rahman, Ahmad
    Ismail, Soran
    Hamid, Rizwan
    Shah, Julian
    BJU INTERNATIONAL, 2010, 106 (10) : 1510 - 1513
  • [45] Surgical Treatment of Urethral Sphincter Mechanism Incompetence in Female Dogs
    McLoughlin, Mary A.
    Chew, Dennis J.
    COMPENDIUM-CONTINUING EDUCATION FOR VETERINARIANS, 2009, 31 (08) : 360 - +
  • [46] The use of the Memokath™ stent in the treatment of detrusor sphincter dyssynergia in spinal cord injury patients:: A single-centre seven-year experience
    Hamid, R
    Arya, M
    Wood, S
    Patel, HRH
    Shah, PJR
    EUROPEAN UROLOGY, 2003, 43 (05) : 539 - 543
  • [47] Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease
    H Petit
    L Wiart
    E Gaujard
    F Le Breton
    J M Ferrière
    A Lagueny
    P A Joseph
    M Barat
    Spinal Cord, 1998, 36 : 91 - 94
  • [48] Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease
    Petit, H
    Wiart, L
    Gaujard, E
    Le Breton, F
    Ferriere, JM
    Lagueny, A
    Joseph, PA
    Barat, M
    SPINAL CORD, 1998, 36 (02) : 91 - 94
  • [49] Sphincterotomy and the treatment of detrusor-sphincter dyssynergia: current status, future prospects
    Reynard, JM
    Vass, J
    Sullivan, ME
    Mamas, M
    SPINAL CORD, 2003, 41 (01) : 1 - 11
  • [50] Combining Transurethral Resection of Fibrous Tissue and Temporary Urethral Stent Insertion Is an Optimal Strategy for Minimally Invasive Treatment of Recurrent and Long Urethral Strictures
    Ahn, Sun-Tae
    Jo, Seon-Beom
    Lee, Hyun-Soo
    Moon, Du-Geon
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)